Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Advaccine logo — Advancing Vaccines，Improving Immunotherapeutics

Advaccine

Advancing Vaccines，Improving Immunotherapeutics

Founded 2009 China China 5 employees Private Equity Total: $236.60M Biopharma, Biotechnology +1

General Information

Company Name Advaccine
Founded Year 2009
Location China China +2
Employees 5
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Private Equity
Social

Get notified when Advaccine moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Advaccine

Advaccine is a biopharmaceutical company founded in 2009 in China, focusing on advancing vaccines and improving immunotherapeutics. The company has a robust pipeline of prophylactic and therapeutic vaccines targeting diseases caused by SARS-CoV-2, respiratory syncytial virus (RSV), and hepatitis B virus (HBV), addressing significant unmet medical needs. Moreover, Advaccine is also developing cancer vaccine candidates, including those for viral-related oncology, neoantigen-based therapeutic vaccines, and tumor-associated antigen therapeutic vaccines. The company recently secured a $6.60M private equity round investment on 05 April 2021, with participation from Matrix Partners China and Hony Capital. With its in-house developed technology platforms and industrial manufacturing capabilities, Advaccine holds promising potential in the biopharma, biotechnology, and pharmaceutical industries. Its dedication to tackling challenging diseases and advancing immunotherapeutics makes it an attractive prospect for investors.

Taxonomy: vaccine development, prophylactic vaccines, therapeutic vaccines, SARS-CoV-2, respiratory syncytial virus, hepatitis B virus, cancer vaccines, biotech, drug discovery, unmet medical needs, innovation, immunotherapy, oncology, viral-related oncology, industrial manufacturing

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 2
Investor Investor
05 Apr 2021
Series B •••••• 4
Investor Investor Investor
•••• •••• 		30 Sep 2020
Venture Round •••••• 2
Investor Investor
01 Feb 2020
Series A •••••• 2
Investor Investor
01 Jan 2017

Advaccine Alternatives & Competitors

Advaccine vs
Valneva
Valneva France

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such a...

Grant
637 employees
Biotechnology, Health Care
Advaccine vs
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. United States

Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and dev...

Grant
15 employees
Biotechnology, Health Care
Advaccine vs
TechnoVax, Inc.
TechnoVax, Inc. United States

TechnoVax is a privately held near-clinical-stage biotechnology company based in Tarrytown, NY speci...

Equity Crowdfunding
5 employees
Health Care
Also compare with: Advaccine vs Evaxion A/S Evaxion A/S

FAQ About Advaccine

Advancing Vaccines，Improving Immunotherapeutics
Advaccine was founded in 2009.
Advaccine is headquartered in China.
Advaccine operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Advaccine has approximately 5 employees.
Advaccine has completed 4 funding rounds, raising a total of $236.60M. The latest funding stage is Private Equity.
Top alternatives and competitors to Advaccine include Valneva, Hawaii Biotech, Inc., TechnoVax, Inc., Evaxion A/S, pHion Therapeutics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Advaccine and Valneva are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Advaccine and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes